Latest current cash for SNPHF: $82B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), SNPHF shows a current cash of $82B. That compares with $64B in the prior-year period — up 28.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNPHF's current cash is now $82B (was $64B) — a 28.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Santen Pharmaceutical , Ltd. is outperforming or lagging.
Tracking SNPHF's current cash over time shows whether Santen Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $82B That compares with $64B in the prior-year period — up 28.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Santen Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $82B) with ownership activity and broader fundamentals.